This study tests a new treatment for GERD (Gastroesophageal Reflux Disease), a condition causing heartburn. The study will compare a drug called MHS-1031, which is a special type of carbohydrate known as a prebiotic, to a placebo, which is a pill with no real medicine. Participants must already be taking PPIs (Proton Pump Inhibitors) like omeprazole to reduce stomach acid, and they should have some improvement in their symptoms.
The study is double-blind, meaning neither the doctors nor the participants know who is getting the real drug or the placebo. Participants will complete online surveys to see how many days they are free from heartburn.
- Study Length: This study includes three phases and lasts around 8 weeks.
- Requirements: Participants need to fill out online questionnaires daily.
- Compensation: Participants may receive compensation for their time and effort.
Those interested should be between 18-75 years old, have internet access, and be on a stable dose of PPIs. People with certain medical conditions or those unable to follow the study rules will not be eligible to participate.